Results 11 to 20 of about 4,973 (174)
ADAR1 Alleviates Inflammation in a Murine Sepsis Model via the ADAR1-miR-30a-SOCS3 Axis
Adenosine deaminase acting on double-stranded RNA 1 (ADAR1) mediates adenosine-to-inosine (A-to-I) RNA editing events. ADAR1 is highly expressed in “septic” macrophages and in small intestinal tissues of mice with sepsis.
Zhou Shangxun +12 more
doaj +3 more sources
Role of ADAR1 on Proliferation and Differentiation in Porcine Preadipocytes
Recent research has identified ADAR1 as a participant in the regulation of lipid accumulation in mice. However, there are no reports on the roles of ADAR1 in proliferation, apoptosis and differentiation of porcine preadipocytes.
Menghuan Yang +5 more
doaj +3 more sources
ADAR1-Mediated RNA Editing and Its Role in Cancer
It is well known that the stability of RNA, the interaction between RNA and protein, and the correct translation of protein are significant forces that drive the transition from normal cell to malignant tumor.
Jizhe Liu +10 more
doaj +3 more sources
The ADAR1 editome reveals drivers of editing-specificity for ADAR1-isoforms [PDF]
Abstract Adenosine deaminase acting on RNA (ADAR) (also known as ADAR1) promotes A-to-I conversion in double-stranded and highly structured RNAs. ADAR1 has two isoforms transcribed from different promoters: ADAR1p150, which is mainly cytoplasmic and interferon-inducible, and constitutively expressed ADAR1p110 that is primarily localized
Renata Kleinova +6 more
openaire +1 more source
The ADAR1 editome reveals drivers of editing-specificity for ADAR1-isoforms
Abstract Adenosine deaminase acting on RNA ADAR1 promotes A-to-I conversion in double-stranded and structured RNAs. ADAR1 has two isoforms transcribed from different promoters: cytoplasmic ADAR1p150 is interferon-inducible while ADAR1p110 is constitutively expressed and primarily localized in the nucleus.
Kleinova, Renata +9 more
openaire +4 more sources
Substrate recognition by ADAR1 and ADAR2 [PDF]
RNA editing catalyzed by ADAR1 and ADAR2 involves the site-specific conversion of adenosine to inosine within imperfectly duplexed RNA. ADAR1- and ADAR2-mediated editing occurs within transcripts of glutamate receptors (GluR) in the brain and in hepatitis delta virus (HDV) RNA in the liver.
S K, Wong, S, Sato, D W, Lazinski
openaire +2 more sources
Early brain-penetrant immunotherapy reverses interferon signature and improves motor outcome in a case of ADAR1-related Aicardi-Goutières syndrome. [PDF]
Abstract Objectives Aicardi‐Goutières syndrome (AGS) is a genetic interferonopathy resulting from defects in nucleic acid metabolism and subsequent enhanced type I interferon signalling. We report how an expedited genomic diagnosis in conjunction with natural history data can enable a long‐term brain‐penetrant anti‐inflammatory regimen to optimise ...
Dale RC +13 more
europepmc +2 more sources
ADAR1 and MicroRNA; A Hidden Crosstalk in Cancer [PDF]
The evolution of cancer cells is believed to be dependent on genetic or epigenetic alterations. However, this concept has recently been challenged by another mode of nucleotide alteration, RNA editing, which is frequently up-regulated in cancer. RNA editing is a biochemical process in which either Adenosine or Cytosine is deaminated by a group of RNA ...
Charles Cho +2 more
openaire +2 more sources
ADAR1-mediated regulation of melanoma invasion [PDF]
AbstractMelanoma cells use different migratory strategies to exit the primary tumor mass and invade surrounding and subsequently distant tissues. We reported previously that ADAR1 expression is downregulated in metastatic melanoma, thereby facilitating proliferation.
Yael Nemlich +9 more
openaire +3 more sources
ADAR1 Editing and its Role in Cancer [PDF]
It is well established that somatic mutations and escape of immune disruption are two essential factors in cancer initiation and progression. With an increasing number of second-generation sequencing data, transcriptomic modifications, so called RNA mutations, are emerging as significant forces that drive the transition from normal cell to malignant ...
Li-Di Xu, Marie Öhman
openaire +2 more sources

